Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsisYuzi Tian, Yongqing Li|JCI Insight|2020Cited by 60
AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment—Efficacy and MechanismTao Dong, Yongqing Li|International Journal of Biological Sciences|2024Cited by 8